poisar

Stock

Apyx Medical Corporation APYX

$3.98+1.92%

Overview

APYX market data

Price History

APYX price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.27
Diluted earnings per share over the trailing twelve months.
Beta
1.42
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.59 – $5.08
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $162.6 · P/B 9.88 · P/S 2.91.

Company news

9 captured
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga · Jul 13, 2026, 11:41 AM
HC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7Benzinga · Jul 13, 2026, 10:12 AM
Apyx Medical Appoints Stavros Vizirgianakis Executive Chairman, Effective June 11Benzinga · Jun 17, 2026, 8:20 PM
8-K filing — Apyx Medical Corp (APYX)SEC EDGAR · Jun 17, 2026, 8:05 PM
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®Globenewswire Inc · May 21, 2026, 12:15 PM
Apyx Medical Publishes New Clinical Data In Aesthetic Surgery Journal Open Forum Highlighting Approach To Improving Cellulite And Skin LaxityBenzinga · May 21, 2026, 12:10 PM
Apyx Medical Announces Publication Of A New Retrospective Investigator-Initiated Study In Plastic And Reconstructive Surgery - Global OpenBenzinga · May 14, 2026, 12:13 PM
Apyx Medical Expands FDA 510(k) Clearance For AYON Body Contouring System To Include Power LiposuctionBenzinga · May 11, 2026, 12:07 PM
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™Globenewswire Inc · May 11, 2026, 12:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock